Immunotherapy of COVID-19: inside and beyond IL-6 signalling

G Zizzo, A Tamburello, L Castelnovo, A Laria… - Frontiers in …, 2022 - frontiersin.org
Acting on the cytokine cascade is key to preventing disease progression and death in
hospitalised patients with COVID-19. Among anti-cytokine therapies, interleukin (IL)-6 …

Autophagy in health and disease: From molecular mechanisms to therapeutic target

G Lu, Y Wang, Y Shi, Z Zhang, C Huang, W He… - MedComm, 2022 - Wiley Online Library
Macroautophagy/autophagy is an evolutionally conserved catabolic process in which
cytosolic contents, such as aggregated proteins, dysfunctional organelle, or invading …

[PDF][PDF] Retracted: meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection

A Hill, A Garratt, J Levi, J Falconer, L Ellis… - Open Forum …, 2021 - academic.oup.com
Ivermectin is an antiparasitic drug being investigated for repurposing against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Ivermectin showed in vitro activity …

[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. Рекомендации Общероссийской общественной …

ЕЛ Насонов, АМ Лила, ВИ Мазуров… - Научно …, 2021 - cyberleninka.ru
В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …

Efficacy and safety of azithromycin in Covid‐19 patients: A systematic review and meta‐analysis of randomized clinical trials

AM Kamel, MSA Monem, NA Sharaf… - Reviews in medical …, 2022 - Wiley Online Library
Azithromycin (AZM) is commonly used in Covid‐19 patients based on low‐quality evidence,
increasing the risk of developing adverse events and antimicrobial resistance. The current …

Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease

M AlQahtani, N Kumar, D Aljawder, A Abdulrahman… - Scientific Reports, 2022 - nature.com
Favipiravir has antiviral activity against influenza, West Nile virus, and yellow fever virus and
against flaviviruses. The objective of this pilot study was to compare three arms: favipiravir; …

Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype

MS Marcolino, KC Meira, NS Guimarães… - BMC Infectious …, 2022 - Springer
Background The role of ivermectin in the treatment of COVID-19 is still under debate, yet the
drug has been widely used in some parts of the world, as shown by impressive market data …

[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и аутоиммунитет

ЕЛ Насонов - Научно-практическая ревматология, 2021 - cyberleninka.ru
Пандемия коронавирусной болезни 2019 (coronavirus disease, COVID-19),
этиологически связанной с вирусом SARS-CoV-2 (severe acute respiratory syndrome …

Consumption trends of antibiotics in Brazil during the COVID-19 pandemic

FS Del Fiol, CC Bergamaschi… - Frontiers in …, 2022 - frontiersin.org
Background: In 2019, a new type of coronavirus emerged and spread to the rest of the world.
Numerous drugs were identified as possible treatments. Among the candidates for possible …

Autophagy-inflammation interplay during infection: Balancing pathogen clearance and host inflammation

Y Pang, L Wu, C Tang, H Wang, Y Wei - Frontiers in Pharmacology, 2022 - frontiersin.org
Inflammation is an essential immune response of the host against infections but is often over-
activated, leading to a variety of disorders. Autophagy, a conserved degradation pathway …